Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDCO | Medicines Company | -1.61% | 47.76 | 20.3% | $139.37m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -2.11% | 23.25 | 14.1% | $136.81m | |
| AMRN | Amarin Corporation Plc Sponsored ADR | -0.24% | 16.71 | 1.8% | $106.43m | |
| PRGO | Perrigo Co. Plc | 0.04% | 55.98 | 6.8% | $65.35m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.03% | 131.41 | 2.3% | $62.65m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -0.99% | 141.01 | 6.2% | $59.44m | |
| SAGE | SAGE Therapeutics, Inc. | -0.69% | 159.79 | 8.6% | $55.88m | |
| MNK | Mallinckrodt Plc | 10.20% | 3.30 | 20.9% | $44.18m | |
| CTLT | Catalent Inc | -1.19% | 51.33 | 2.4% | $42.63m | |
| ENDP | Endo International Plc | -2.02% | 3.88 | 8.8% | $39.68m | |
| UTHR | United Therapeutics Corporation | 1.09% | 80.69 | 14.3% | $30.77m | |
| PTLA | Portola Pharmaceuticals, Inc. | 0.72% | 30.68 | 6.7% | $30.44m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.22% | 68.90 | 16.9% | $29.88m | |
| ICLR | ICON Plc | 0.25% | 149.92 | 4.1% | $28.03m | |
| AERI | Aerie Pharmaceuticals, Inc. | -4.41% | 22.09 | 6.8% | $26.55m |
Company Profile
Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.